Certified by Founder Lodge
RA Capital Management, L.P.
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $160,000,000
50 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing
| Company | Date | Round | Raised |
|---|---|---|---|
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Carmot Therapeutics, Inc. |
July, 26 ,2022 | Series D | $160,000,000 |
 Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 NAPIGEN, INC. |
July, 12 ,2022 | Seed | $7,900,000 |
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 ExcepGen |
August, 25 ,2023 | Unknown | $4,000,000 |
 Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 Superluminal Medicines Inc. |
September, 04 ,2023 | Seed | $33,000,000 |
 Selux Diagnostics, Inc |
March, 01 ,2022 | Series C | $50,000,000 |
 Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
 Cortica |
April, 19 ,2023 | Unknown | $75,000,000 |
 Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
 Convergent Therapeutics, Inc. |
May, 04 ,2023 | Series A | $90,000,000 |
 Vaxess Technologies |
September, 14 ,2023 | Unknown | $9,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 Pluton Biosciences |
May, 25 ,2023 | Series A | $16,500,000 |
 Commons Clinic |
October, 10 ,2023 | Series A | $19,500,000 |
 SpyGlass Pharma, Inc. |
July, 11 ,2023 | Series C | $90,000,000 |
 Ventricle Health |
October, 20 ,2023 | Seed | $8,000,000 |
| Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Rampart Bioscience |
October, 25 ,2023 | Series A | $85,000,000 |
| Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| ExcepGen |
August, 25 ,2023 | Unknown | $4,000,000 |
 Forward Therapeutics, Inc. |
November, 09 ,2023 | Series A | $50,000,000 |
| Superluminal Medicines Inc. |
September, 04 ,2023 | Seed | $33,000,000 |
 Nature's Toolbox, Inc. (NTx) |
November, 17 ,2023 | Series B | $47,500,000 |
| Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
 AM Batteries |
December, 05 ,2023 | Series B | $30,000,000 |
| Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
 FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
| Vaxess Technologies |
September, 14 ,2023 | Unknown | $9,000,000 |
 Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Commons Clinic |
October, 10 ,2023 | Series A | $19,500,000 |
 Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Ventricle Health |
October, 20 ,2023 | Seed | $8,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Rampart Bioscience |
October, 25 ,2023 | Series A | $85,000,000 |
| Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| Forward Therapeutics, Inc. |
November, 09 ,2023 | Series A | $50,000,000 |
| Nature's Toolbox, Inc. (NTx) |
November, 17 ,2023 | Series B | $47,500,000 |
| AM Batteries |
December, 05 ,2023 | Series B | $30,000,000 |
| FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
